Clinical Trial Update: Differentiation of Bone Sarcomas and Osteomyelitis With Ferumoxytol-Enhanced MRI [Phase 2]

View source ↗

Summary

Phase 2 clinical trial updating the use of ferumoxytol-enhanced MRI to differentiate bone sarcomas from osteomyelitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Cancer
• Bone Necrosis
• Bone Sarcoma
• Chondrosarcoma
• Ewing Sarcoma
• Osteomyelitis
• Osteosarcoma
• Rhabdomyosarcoma

Drugs mentioned

• ferumoxytol-enhanced MRI

Snippet

Sponsor: Heike E Daldrup-Link | Conditions: Bone Cancer, Chondrosarcoma | Phase 2 | Status: COMPLETED | Results posted: 2019-06-18